UBE2N and prostate carcinoma: The result of the GSEA displayed the positive correlations between UBE2N expression and “HALLMARK_GLYCOLYSIS”, “KEGG_OXIDATIVE_PHOSPHORYLATION”, “REACTOME_SIGNALING_BY_WNT”, or “HALLMARK_MYC_TARGETS_V1” in patients with prostate cancer (Figure S1).